NAMCO BANDAI Holdings Inc. Consolidated Financial Results for the Third Quarter Ended December 31, 2006

NAMCO BANDAI Holdings experienced a complex fiscal period during the third quarter ending December 31, 2006, characterized by a contraction in core revenue streams alongside strategic financial adjustments. The company recorded net sales of ¥330,517 million and operating income of ¥32,235 million, marking year-over-year declines of 4.3% and 9.5%, respectively. Despite these operational headwinds, net income rose by 12.3% to ¥19.9 billion, a result primarily driven by the divestiture of shares in Tohato, Inc. rather than organic growth within the primary business units.

Performance across the company’s diverse segments remained inconsistent throughout the quarter. The Game Contents and Visual & Music divisions faced significant pressure due to shifted product launch schedules and broader market uncertainty surrounding the adoption of next-generation gaming consoles. Domestically, the organization struggled with declining sales in the girls' toy segment and a weakening mobile content business. While international operations provided some stability—specifically through reduced operating losses in the Americas and growth within the Asian market—these gains were insufficient to offset domestic volatility, leading management to lower the full-year net sales forecast by 2.1%.

To address these challenges, the company initiated a comprehensive group restructuring, reorganizing business segments and transferring specific operations to better align with its strategic business units. These structural changes were accompanied by improved financial discipline, as evidenced by an increase in cash flow from operating activities to ¥24.6 billion and a reduction in net cash used for investing activities. By streamlining its internal organization and focusing on capital efficiency, the company sought to mitigate the impact of its shifting product pipeline and stabilize its long-term market position within the global entertainment industry.